This inventor holds 1 USPTO granted patent. Top assignee: Ultragenyx Pharmaceutical Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Fabrice Dufour: Innovator in Sialic Acid Crystallization
Introduction
Fabrice Dufour is a notable inventor based in Hanau-Mittelbuchen, Germany. He has made significant contributions to the field of biochemistry, particularly in the area of sialic acid. His work has implications for therapeutic applications, showcasing the importance of innovation in medical science.
Latest Patents
Fabrice Dufour holds a patent for "Crystal forms of sialic acid or salt or solvate thereof." This invention includes crystalline forms of N-acetylneuraminic acid (NeuAc) and its salts and/or solvates. The patent also covers compositions that comprise these crystalline forms and their therapeutic uses, highlighting the potential benefits of his work in treating various medical conditions.
Career Highlights
Dufour's career is marked by his dedication to research and development in pharmaceutical sciences. He is currently associated with Ultragenyx Pharmaceutical Inc., where he continues to explore innovative solutions in drug development. His expertise in crystallization processes has positioned him as a valuable asset in the industry.
Collaborations
Fabrice has collaborated with notable colleagues, including John Klopp and Hayley Reece. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in their field.
Conclusion
Fabrice Dufour's contributions to the field of sialic acid crystallization exemplify the impact of innovation in pharmaceuticals. His patent and ongoing work at Ultragenyx Pharmaceutical Inc. reflect his commitment to advancing medical science.